DUN T1 Israeli Company
DUN T1 is an early-stage R&D company that develops an orally administered drug for type 1 diabetes. DUN T1's vision is to develop a proactive approach towards treatment and early diagnosis. DUN T1's novel natural ingredient is patented, safe, and effective.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Meishar, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/dun-t1
External links are provided for reference and verification purposes.